Peter Kaemmerer, M.D. | Association for Accessible Medicines
THANK YOU - for all those who made our first-ever #GRxBiosims virtual conference a success.

Peter Kaemmerer, M.D.

AAM Board Member
Chief Executive Officer, Sagent Pharmaceuticals, Inc.
Peter Kaemmerer​
Peter Kaemmerer, M.D.
Sagent Pharmaceuticals, Inc

Peter Kammerer serves as CEO for Sagent Pharmaceuticals.​

Peter was previously CEO of DKSH Japan. Prior to this, he spent 16 years at Landesbank Baden-Wuerttemberg, assuming several executive roles across the globe, including serving as a member of the Board of Managing Directors. He is currently a member of the Advisory Board of Goetzpartners in Muenchen, Germany. Peter has over 30 years of executive leadership experience in positions spanning Japan, Germany and the U.S.

Peter earned a Doctor of Law degree at the University of Munich and an MBA at INSEAD, Fontainebleau, France.​

Latest Tweets

Association for Accessible Medicines

202.249.7100

Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.